DATE/TIME
September 18, 2:30 – 3:00 PM EST
TITLE
Normalization of the Pipeline: The Science vs. Funding Battle
SPEAKER
David H. Windley, CFA, CPA
Managing Director, Jefferies LLC
ABSTRACT
Join Dave Windley, Managing Director at Jefferies, as he unpacks the shifting dynamics between scientific innovation and financial realities in biopharma. In this timely session, Normalization of the Pipeline: The Science vs. Funding Battle, Windley explores how investment pressures and evolving capital markets are shaping the pace and direction of drug development.
BIO
Dave Windley is a managing director and founding member of Jefferies’ Healthcare Equity Research team. Over a 25-year career in investment research, Mr. Windley has covered a broad range of healthcare product and service sectors, including managed care, healthcare information technology, pharmaceutical services, and specialty pharmaceuticals. Dave is a five-time Wall Street Journal Best on the Street honoree and a 6-time Starmine award recipient. Dave is involved in the Nashville financial and healthcare community, having served on boards of the CFA Society Nashville and Owen Graduate School of Management. Dave also enjoys mentoring start-up companies. Dave earned his Masters of Business Administration from the Owen School at Vanderbilt University and his BA from Transylvania University. Dave is a CFA charter holder and certified public accountant.
